Organ Rejection T-cell Biology Immunosuppressants are all designed to inhibit T-cell activation, a two-part process consisting of the sensitization and effector stages. The sensitization stage involves an interaction between antigen presenting cells (APC, e.g. dendritic cells, which load their antigens onto the MHC molecules for display) and host T-cells. The effector stage involves stimulation by […]